11-47565644-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_175732.3(PTPMT1):āc.22G>Cā(p.Glu8Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000126 in 1,350,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_175732.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTPMT1 | NM_175732.3 | c.22G>C | p.Glu8Gln | missense_variant | 1/4 | ENST00000326674.10 | |
PTPMT1 | NM_001143984.2 | c.22G>C | p.Glu8Gln | missense_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTPMT1 | ENST00000326674.10 | c.22G>C | p.Glu8Gln | missense_variant | 1/4 | 1 | NM_175732.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 151970Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000751 AC: 9AN: 1198316Hom.: 0 Cov.: 30 AF XY: 0.0000104 AC XY: 6AN XY: 579688
GnomAD4 genome AF: 0.0000526 AC: 8AN: 151970Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74226
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2023 | The c.22G>C (p.E8Q) alteration is located in exon 1 (coding exon 1) of the PTPMT1 gene. This alteration results from a G to C substitution at nucleotide position 22, causing the glutamic acid (E) at amino acid position 8 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at